In heterogeneous catalysis, the catalyst is in a different phase from the reactants. Application In Synthesis of 3,6-Dichloropyridazine, At least one of the reactants interacts with the solid surface in a physical process called adsorption in such a way. 141-30-0, name is 3,6-Dichloropyridazine. In an article，Which mentioned a new discovery about 141-30-0
COMPOUNDS AND THEIR USE AS BACE INHIBITORS
The present application relates to compounds of formula (I), (la), or (lb) and their pharmaceutical compositions/preparations. This application further relates to methods of treating or preventing Alphabeta-related pathologies such as Down’s syndrome, beta- amyloid angiopathy such as but not limited to cerebral amyloid angiopathy or hereditary cerebral hemorrhage, disorders associated with cognitive impairment such as but not limited to MCI (“mild cognitive impairment”), Alzheimer’s disease, memory loss, attention deficit symptoms associated with Alzheimer’s disease, neurodegeneration associated with diseases such as Alzheimer’s disease or dementia, including dementia of mixed vascular and degenerative origin, pre-senile dementia, senile dementia and dementia associated with Parkinson’s disease.
I hope this article can help some friends in scientific research. I am very proud of our efforts over the past few months and hope to 141-30-0, help many people in the next few years.Application In Synthesis of 3,6-Dichloropyridazine
Reference：
Pyridazine – Wikipedia,
Pyridazine | C4H4N1246 – PubChem